Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canadian Multicenter Observational Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Patients

NCT01706107 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT01706107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01706107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canadian Multicenter Observational Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Patients
Lead sponsor
Biogen
Phase
Observational
Overall status
Terminated
Start date
November 7, 2012
Completion date
October 2, 2015
Enrollment
73 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing-remitting multiple sclerosis